Dan Strange

Dan, CTO and Co-founder of Cellular Origins, is dedicated to solving the challenge of scalable cell therapy manufacturing. With 15 years of experience at the intersection of biology and engineering, Dan completed his PhD at Cambridge University, where he designed and automated tissue engineering bioprocesses. He then joined TTP, collaborating with clients on medical device design and cell therapy automation, playing a key role in developing five modular cell therapy automation systems. Now, as CTO of Cellular Origins, Dan leads the technical vision and development of the Constellation™ automated cell therapy manufacturing platform, enabling scalable, cost-effective, and space-efficient cell therapy production.